GlassScriptPhysician profile
Stephen V Dimarzo
NPI 1366479461
$1,633.50
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $764 · 2020: $70.13 · 2021: $16.70 · 2022: $379 · 2023: $139 · 2024: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $357.97 | 2022-2023 | Nexplanon |
| Astellas Pharma US INC | $273.06 | 2023-2024 | Veozah |
| Pfizer INC. | $157.87 | 2019 | |
| Abbvie INC. | $113.40 | 2019-2022 | |
| Allergan, INC. | $87.69 | 2019 | |
| Therapeuticsmd, INC. | $85.77 | 2019-2022 | |
| Avion Pharmaceuticals | $78.21 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $73.09 | 2019-2020 | |
| Mission Pharmacal Company | $66.22 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $60.10 | 2019-2020 | |
| Becton, Dickinson and Company | $55.97 | 2024 | Arista Ah Flexitip |
| Roche Diagnostics Corporation | $36.68 | 2019 | |
| Duchesnay USA Incorporated | $31.46 | 2019 | |
| Daiichi Sankyo INC. | $31.05 | 2019 | |
| Exeltis, USA INC. | $30.88 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $23.02 | 2023 | Ova1 |
| Hologic Sales and Service, LLC | $14.83 | 2024 | Novasure, Acessa Provu System |
| Mayne Pharma Commercial LLC | $14.80 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.55 | 2019 | |
| Minerva Surgical, INC | $14.39 | 2019 | |
| Dysis Medical, INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Dimarzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.